Table 5 Profile of patients with hematological side effects
| Characteristics | Leukocytosis | Neutropenia | Agranulocytosis |
|---|---|---|---|
| Age | |||
| 20–29 | 2 | 3 | 1 |
| 30–39 | 4 | 0 | 0 |
| 40–49 | 1 | 0 | 1 |
| More than 49 | 0 | 1 | 0 |
| Gender | |||
| Male | 5 | 3 | 2 |
| Female | 2 | 1 | 0 |
| Dose of clozapine (mgs) | |||
| Median (range) | 300 (200–400) | 450 (150–800) | 600 (400–800) |
| Antipsychotics used prior to clozapine | |||
| Haloperidol | 4 | 3 | 1 |
| Chlorpromazine | 0 | 0 | 1 |
| Olanzapine | 6 | 2 | 1 |
| Resperidone | 2 | 3 | 1 |
| Quetiapine | 0 | 0 | 0 |
| Amisulpride | 2 | 0 | 0 |
| Aripiprazole | 0 | 0 | 1 |
| Paliperidone | 0 | 0 | 0 |